This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Pharmaceutical Care in VA Nursing Home

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2014 by Taichung Veterans General Hospital.
Recruitment status was:  Active, not recruiting
Information provided by (Responsible Party):
Taichung Veterans General Hospital Identifier:
First received: March 29, 2013
Last updated: August 27, 2014
Last verified: August 2014

This study investigates the effect of pharmaceutical care on a Veteran nursing home. 100 patients will be selected into this controlled study.The hypothesis are:

  1. After patients receive pharmaceutical care, their drug related problems will be decreased.
  2. After patients received pharmaceutical care, their self-reported medical expenditure will be decreased.

Condition Intervention
Focus on the Elderly in a Nursing Home Other: Pharmaceutical care

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: The Impacts of Pharmaceutical Cares on the Elderly in a VA Nursing Home.

Resource links provided by NLM:

Further study details as provided by Taichung Veterans General Hospital:

Primary Outcome Measures:
  • potential inappropriate medication (PIA) [ Time Frame: one year ]

Secondary Outcome Measures:
  • drug items used [ Time Frame: one year ]
    the controlled group is expected to have less drug items used.

  • medical expenditure [ Time Frame: one year ]
    subjects self-reported outpatients visit, hospitalization, drug, and healthy supplemental used.

Other Outcome Measures:
  • quality of life measure [ Time Frame: one year ]
    use health outcome measure, EQ-5D, to assess the quality of life issue.

Estimated Enrollment: 100
Study Start Date: April 2013
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Non-pharmaceutical care
Veterans do not receiving pharmaceutical care
Pharmaceutical care
Veterans receiving pharmaceutical care
Other: Pharmaceutical care
pharmacists provide pharmaceutical care to the intervention group, comparing to ordinary care in control group

Detailed Description:

Around 200 residents in a Veteran nursing home will be selected for reviewing inclusion and exclusion criteria. A total of 100 subjected are selected into this randomized controlled trial. Each group will have 50 subjects and then divides into 4 subgroup, according to their drug items used (5-7 and over 8 items used).

The inclusion criteria:

  1. Residents of the Veteran nursing home.
  2. over 65 years old.
  3. complete comprehensive geriatric assessment (CGA)
  4. prescription drugs more than 4 times/day, excluding stat order.
  5. with 2 or more chronic diseases.

Exclusion criteria:

1. residents who were in the pharmaceutical care project of Taiwan Pharmacists Association.


Ages Eligible for Study:   65 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Resident from a Veteran nursing home and willing to receive the pharmaceutical care by pharmacists.

Inclusion Criteria:

  • Residents in the Veteran nursing home
  • Age over 65 years old
  • Complete Comprehensive Geriatric Assessment (CGA)
  • Use more than 4 drug item per day (excluding stat order)
  • subjects with more than 2 chronic diseases.

Exclusion Criteria:

  • subjects who were in pharmaceutical care project of Taiwan Pharmacist Association.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01823757

Changhua Domiciliar Center
Changhua City, Taiwan
Sponsors and Collaborators
Taichung Veterans General Hospital
Principal Investigator: Wen-Shyong Liou, PhD Taichung Veteran General Hospital
  More Information

Responsible Party: Taichung Veterans General Hospital Identifier: NCT01823757     History of Changes
Other Study ID Numbers: VGHTCPHARMACY1
TCVGHPHARM_RESEARCH_1 ( Other Identifier: Taichung Veteran General Hospital )
Study First Received: March 29, 2013
Last Updated: August 27, 2014

Keywords provided by Taichung Veterans General Hospital:
potential inappropriate medications
pharmaceutical care
quality of life
medical expenditure processed this record on September 21, 2017